Want to join the conversation?
Adam Jonas of Morgan Stanley asks about an update on the company's proprietary mapping initiatives. $TSLA said it won't be able to give the in-depth details but there is a need to have much high definition maps than that currently exist to have full autonomy. The company is in the process of building those and is making good progress.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.